Korean Drug Co., Ltd. (KOSDAQ:014570)

Market Cap	46.10B -8.1%
Revenue (ttm)	62.51B -14.4%
Net Income	6.51B +117.4%
EPS	n/a
Shares Out	10.91M
PE Ratio	7.08
Forward PE	n/a
Dividend	160.00 (3.79%)
Ex-Dividend Date	Dec 29, 2025

Volume	24,882
Average Volume	18,587
Open	4,225.00
Previous Close	4,225.00
Day's Range	4,130.00 - 4,225.00
52-Week Range	3,600.00 - 5,170.00
Beta	0.29
RSI	60.34
Earnings Date	May 14, 2026

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 270
• Stock Exchange: KOSDAQ
• Ticker Symbol: 014570

Financial Performance

In 2025, Korean Drug's revenue was 62.51 billion, a decrease of -14.37% compared to the previous year's 73.00 billion. Earnings were 6.51 billion, an increase of 117.42%.